Skip to main content
. Author manuscript; available in PMC: 2009 Dec 9.
Published in final edited form as: Vaccine. 2008 Oct 16;26(52):6874–6882. doi: 10.1016/j.vaccine.2008.09.077

Figure 10. Characterization of protective immune serum.

Figure 10

Immune sera obtained from mice treated with levofloxacin at 72 hours post-infection, which showed protection in passive transfer experiments (Figures 8 and 9), was characterize by ELISA for SCHU S4 specificity. Titers were calculated as the lowest dilution of serum that gave an OD of 0.1 above the normal serum control.